Biotechnology
Usa
Enzymes
Industrial
Development
Commercialization
High
Performance
M&A Advisory
Lazard
Full Credential Description
Verenium. United States. Announced Date 28/08/2009. Closed Date 28/08/2009. Deal value: $28m. Convertible notes exchange. Industry: Verenium is a biotechnology company specializing in the development and commercialization of high-performance enzymes for industrial processes.